This European Annual Conference draws pharmaceutical and biopharmaceutical professionals at all levels of the industry - from students and emerging leaders to the most senior executives in drug manufacturing, supply chain, devices, equipment and services, and global regulatory agencies. We welcome you to participate at the 2024 ISPE Europe Annual Conference to learn and share progress, success stories, best practices and lessons learned.
The 2024 Europe Annual Conference Programme Committee is requesting proposals aligning with the following content areas:
The aim is to explore the potential of Digital Transformation and Pharma 4.0™ projects within the Life Science Industry. Enabling technologies alone are not the answer to challenges that our industry has to face, but they are a key element of a wider solution, inclusive of revised business and compliance processes, innovative and sustainable digital solutions and equipment, and, as a key enabler, new organization and culture.
Inspections and compliance assessment remain a core aspect of pharmaceutical regulation. In recent years there has been increasing focus on internationally harmonized standards across the pharmaceutical development lifecycle. This enhances risk-based audit and inspection models and facilitates reliance. As this practice adapts to new industry ways of working, there is increasing expectation for knowledge sharing across GxPs and learning from the inspections of other organizations.
Improving the availability of authorized medicines is a key priority for the medicines regulatory network. Drug shortages can occur for many reasons, such as manufacturing difficulties, problems affecting the quality of medicines or increased demand that can impact on patient care. Shortages or other problems with the availability of medicines create challenges for the medicine supply chain, with a potentially serious impact on human health. Managing drug shortages is critical to ensure patient safety. Directing drug shortages requires an immediate short-term strategy and long-term strategic plans.
Attendees will learn the ins and outs of the European projects that were recognized with the ISPE Facility of the Year Award (FOYA) in 2023, with presentations and discussions on engineering and project delivery with case studies.
Join our speakers and other subject matter experts to hear about several areas of interest in the computer system validation area, including how GAMP 5 Second Edition has had an impact on the pharmaceutical industry, the current FDA position on Computer Software Assurance (CSA), how organisations are adapting to a CSA environment, the significant areas of progress and, conversely the remaining challenges.
The International Society of Pharmaceutical Engineering’s (ISPE) Women in Pharma® group was established in 2017. Since its inception, it has grown to a community of more than 2,000 members who are actively engaged in educational, collaborative, and networking activities designed to bridge gender, cultural, organizational, and geographic boundaries, maximize the impact women have in...
The ISPE GAMP® 5 Guide (Second Edition) was published on 29 July 2022. It was presented and discussed at the 2023 ISPE Europe Annual Conference, the 2023 ISPE Annual Meeting & Expo, and at several local...
The importance of the 2024 ISPE Europe Annual Conference is evident with the continuous challenges the pharmaceutical industry is facing in terms of drug shortages, regulatory requirements, digitalization, automation, and big data management.
